What I Wish I Had Known Earlier: How Timing May Help You Avoid Joint Replacement in Dallas
- cassis101
- Jan 25
- 3 min read
By Deborah Westergaard, MD | Pain Experts | Dallas–Plano
Why Joint Replacement Becomes the Default Too Early
Many people assume that once a surgeon recommends joint replacement, the path forward is settled. The diagnosis feels definitive. The plan feels inevitable.
But in reality, joint replacement is often a default. Not because it is always the only solution, but because it is the solution most familiar to the system.
Outstanding surgeons, ethical, skilled, and well-intentioned are trained primarily in operative pathways. Most have limited exposure to advanced regenerative medicine, and many have not followed enough patients longitudinally to fully appreciate how biologic strategies can alter joint trajectories before replacement becomes necessary.
That gap matters.
Because between early degeneration and irreversible structural failure, there is often a window of opportunity, a period where joint environment, stability, and supportive tissues may still respond to biologic intervention.
That window is frequently overlooked.
A Personal Perspective on Missed Timing
In 2008, I was 48 years old and training for the Miami Half Marathon. I was strong, lean, and highly active. At the time, I believed that conditioning alone protected joints. I did not yet appreciate how cumulative load, subtle instability, and biologic fatigue quietly erode joint integrity long before symptoms escalate.
A fall resulted in a significant hip labral tear. The recommended solution was surgical repair, and I proceeded with surgery performed by an excellent orthopedic surgeon. The procedure itself was technically sound.
What I did not realize then was that image-guided regenerative treatments for labral pathology already existed, even at that time. They were not widely discussed. They were not standard. And I did not yet have the clinical experience to understand where they might fit.
For years afterward, I functioned well, until the labrum tore again, more extensively. A large paralabral cyst developed, extending into the bone and compromising joint structure. At that point, biologic treatment was no longer early intervention. It was an attempt to delay the inevitable.
The hip became unstable. Another fall worsened the damage. Ultimately, joint replacement became necessary.
What stands out in hindsight is not regret, but clarity:
There was likely a period of time when biologic intervention might have supported the joint enough to change its course. That window passed before I fully understood it.
The Solution: Using Regenerative Medicine to Avoid Joint Replacement
Avoid Joint Replacement Dallas — Understanding the “In-Between Window”
Today, we understand far more about joint degeneration as a systems problem, not a single-structure failure.
Labral tears, ligament laxity, capsular instability, subchondral bone stress, and cartilage nutrition are interconnected. Addressing only the end-stage cartilage loss without considering the structures that failed first often accelerates decline.
When applied early and precisely, regenerative treatments such as platelet-rich plasma and bone marrow–derived orthobiologics may help:
Support joint stability
Improve the biologic environment of cartilage
Reduce progressive structural breakdown
Delay or in some cases help avoid joint replacement
This does not replace surgery. It repositions surgery as one option among several, rather than the immediate endpoint.
4
Importantly, this approach does not require a surgeon to be “wrong.”It simply acknowledges that different training paths emphasize different solutions.
A surgeon may be brilliant at surgery—and still not immersed in regenerative medicine. That does not diminish surgical expertise. It highlights the value of collaborative, timing-based decision-making.
What the Clinical Evidence Is Beginning to Show
While hip-specific data are still emerging, orthopedic literature already demonstrates that a substantial percentage of patients initially considered candidates for joint replacement particularly knees were able to avoid or significantly delay replacement following appropriately dosed bone marrow–based procedures.
Hip-focused studies are underway, but the principle remains consistent across joints:
Earlier biologic intervention preserves options. Later intervention narrows them.
Once bone architecture collapses or instability becomes advanced, biologic strategies are far less effective. Timing is everything.
Why This Matters to High-Performing Individuals
For people who value performance, longevity, and intelligent risk management, the true cost is not the procedure itself.
It is:
Loss of optionality
Premature irreversibility
Decisions made before all tools are considered
Joint replacement is permanent. Timing is not.
Understanding when surgery is necessary—and when it may be premature—is a strategic advantage.
A Smarter Question Before Surgery
If you have been told that joint replacement is the next step, it may still be reasonable to ask:
Is there residual biologic capacity in this joint?
Are supportive structures contributing to degeneration?
Is there a window where regenerative medicine could stabilize the joint enough to avoid joint replacement or at least buy meaningful time?
In my Dallas practice, I help patients navigate that in-between space, after diagnosis, before irrevocable surgery, using careful imaging, disciplined analysis, and evidence-based regenerative strategies.
No guarantees. No pressure. Just clarity.
Before committing to joint replacement, it is reasonable to explore whether a regenerative approach could preserve your joint longer, without disturbing native anatomy.
#AvoidJointReplacement#OrthobiologicsDallas#RegenexxDallas#RegenerativeMedicineDallas#JointPreservation
Comments